Innovating Works

KILIMANJARO CHRISTIAN MEDICAL CENTRE GSF...

Desconocido
PROTID: Randomised Controlled Trial of Preventive Treatment of Latent Tuberculosis Infection in Patients wit... THE GOOD SAMARITAN FOUNDATION participó en un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2023-01 Diabetes Mellitus (DM) contributes to an estimated 11.3% of adult deaths worldwide. Approximately 1 in 10 adults globally are estimated to h...
2024-05-18 - 2026-12-31 | Financiado
GREAT-LIFE: Linking Infectious disease Front-liners’ control Efforts with central public health authorities in T... THE GOOD SAMARITAN FOUNDATION participó en un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2022-01 The African Great Lakes region is one of the most densely populated areas in Africa and also one of the areas globally with the highest biod...
2023-06-13 - 2028-06-30 | Financiado
BREEDIME: Building resilient research ethics, Diagnostics and medicines regulatory capacity during routine and... THE GOOD SAMARITAN FOUNDATION participó en un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2022-01 An effective and strong regulatory system for health technologies is critical, especially during epidemics and pandemic situations. The dema...
2023-05-02 - 2026-05-31 | Financiado
DI-DIDA: Digital Innovations and Diagnostics for Infectious Diseases in Africa THE GOOD SAMARITAN FOUNDATION participó en un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 The DI-DIDA project's overall objective is to tackle poverty-related infectious diseases in sub-Saharan Africa and African islands by i) str...
2022-08-17 - 2027-09-30 | Financiado
REDMAL: Clinical development of a Pfs48 45 based malaria transmission blocking vaccine THE GOOD SAMARITAN FOUNDATION participó en un FP7: Malaria vaccines are needed to reduce the unacceptably high burden of disease and death in particular in the lowest income countries. Malari...
Financiado
MALACTRES: Multi drug resistance in malaria under combination therapy Assessment of specific markers and devel... THE GOOD SAMARITAN FOUNDATION participó en un FP7: This project aims to assess specific P. falciparum genetic markers for resistance to artemisinin-based combinations (ACT), and to develop in...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.